Stryker Operating Cycle from 2010 to 2026

SYK Stock  USD 366.05  0.20  0.05%   
Stryker Operating Cycle yearly trend continues to be quite stable with very little volatility. The value of Operating Cycle is projected to decrease to 195.02. From the period between 2010 and 2026, Stryker, Operating Cycle regression line of its data series had standard deviation of  28.11 and standard deviation of  28.11. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
258.83645091
Current Value
195.02
Quarterly Volatility
28.11431432
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Stryker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stryker's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 B, Interest Expense of 637.4 M or Total Revenue of 26.4 B, as well as many indicators such as Price To Sales Ratio of 3.06, Dividend Yield of 0.0054 or PTB Ratio of 6.39. Stryker financial statements analysis is a perfect complement when working with Stryker Valuation or Volatility modules.
  
Build AI portfolio with Stryker Stock
Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
Historical Operating Cycle data for Stryker serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Stryker represents a compelling investment opportunity.

Latest Stryker's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Stryker over the last few years. It is Stryker's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stryker's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Stryker Operating Cycle Regression Statistics

Arithmetic Mean251.20
Geometric Mean249.70
Coefficient Of Variation11.19
Mean Deviation23.47
Median253.51
Standard Deviation28.11
Sample Variance790.41
Range101
R-Value0.36
Mean Square Error731.86
R-Squared0.13
Significance0.15
Slope2.02
Total Sum of Squares12,647

Stryker Operating Cycle History

2026 195.02
2025 258.84
2024 266.67
2023 287.89
2022 267.34
2021 253.51
2020 296.51

About Stryker Financial Statements

Stryker investors utilize fundamental indicators, such as Operating Cycle, to predict how Stryker Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 258.84  195.02 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Stryker assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
0.559
Dividend Share
3.4
Earnings Share
8.38
Revenue Per Share
65.714
Quarterly Revenue Growth
0.114
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Stryker's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.